Skip to main content

Closed

TRVI: Trevi Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-30.5%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio24.75×

Trevi Therapeutics, Inc.

TRVINASDAQ Global Market·USD·Closed

Trevi Therapeutics, Inc.

TRVINASDAQ·USD·Closed

$18.25

−0.82%

$18.25

−$0.15 (0.82%)

52W Range

86thpctl

Volume

0.62×avg

Mkt Cap

2.59BUSD

P/E

-56.6TTM

Div Yield

–ann

52W Range

86thpctl

Volume

0.62×avg

Market Cap

2.59BUSD

P/E Ratio

-56.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings